IMAX’s Richard Gelfond plans $11M stock sale

IMAX CORP (IMAX) is the issuer of common shares that a person named Richard Gelfond plans to sell under Rule 144.

Rhea-AI Filing Summary

IMAX CORP (IMAX) is the issuer of common shares that a person named Richard Gelfond plans to sell under Rule 144. A broker, Goldman Sachs & Co. LLC, is listed to sell 205,504 shares of common stock, with an aggregate market value of $11,037,619.84, on or after August 19, 2026. The shares were originally acquired as compensation via stock options and will be disposed of through a cashless exercise / same-day sale. IMAX common stock is listed on the NYSE, and there were 54,842,114 shares outstanding at the time referenced for this notice. In the prior three months, Gelfond reported sales of 151,253 shares for total consideration of $7,714,644.14. The filing states these transactions are made under a selling plan dated May 19, 2026 intended to comply with Rule 10b5-1(c).

Key Figures

Planned shares to be sold: 205,504 shares Aggregate market value of planned sale: $11,037,619.84 Shares outstanding: 54,842,114 shares +4 more

7 metrics

Planned shares to be sold 205,504 shares Common stock to be sold through Goldman Sachs & Co. LLC under Rule 144

Aggregate market value of planned sale $11,037,619.84 Market value of 205,504 IMAX common shares covered by this notice

Shares outstanding 54,842,114 shares IMAX common shares outstanding as referenced in the notice

Shares sold in past three months 151,253 shares Prior IMAX common shares sold by Richard Gelfond during the last 3 months

Value of past three months’ sales $7,714,644.14 Total consideration received for 151,253 shares sold in the last 3 months

Planned sale date 08/19/2026 Proposed date of sale for the 205,504 IMAX common shares

Selling plan date 05/19/2026 Date of selling plan intended to comply with Rule 10b5-1(c)

Key Terms

Rule 144, Rule 10b5-1(c), cashless exercise / same-day sale, Common

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Rule 10b5-1(c) regulatory

"selling plan dated 05/19/2026, that is intended to comply with Rule 10b5-1(c)."

Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.

cashless exercise / same-day sale financial

"Compensation -- Cashless exercise / same-day sale"

Common financial

"Common | Goldman Sachs & Co. LLC 200 West Street"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IMAX (IMAX) shares are planned to be sold under this Rule 144 notice?

The notice covers a planned sale of 205,504 IMAX common shares. These shares are to be sold through Goldman Sachs & Co. LLC, with an aggregate market value stated as $11,037,619.84 on the form.

What is the aggregate market value of IMAX (IMAX) shares covered by this filing?

The aggregate market value of the 205,504 IMAX shares covered is reported as $11,037,619.84. This figure reflects the market value used for the Rule 144 notice at the time of the planned sale.

How many IMAX (IMAX) shares did Richard Gelfond sell in the past three months?

In the past three months, 151,253 IMAX common shares were sold for total proceeds of $7,714,644.14. These prior sales are disclosed in the section describing securities sold during the last three months.

How many IMAX (IMAX) shares were outstanding according to this Rule 144 filing?

The filing lists 54,842,114 IMAX common shares outstanding. This figure provides context for the volume of shares being sold relative to the company’s total outstanding common stock at the referenced time.

Was the IMAX (IMAX) share sale made under a Rule 10b5-1 trading plan?

Yes. The remarks state the sales are made under a selling plan dated May 19, 2026 that is intended to comply with Rule 10b5-1(c), which governs pre-arranged trading plans for insiders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 06:29 PM Accepted by SEC EDGAR 08/19/2026 - 06:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000944011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IMAX Corporation
SEC File Number	001-35066
Address of Issuer	2525 Speakman Drive Mississauga Unknown L5K 1B1
Phone	1-905-403-6457
Name of Person for Whose Account the Securities are To Be Sold	Richard Gelfond
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	205504	11037619.84	54842114	08/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/03/2017	Acquired as compensation -- Stock Options	Issuer			205504	01/03/2017	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	08/18/2026	151253	7714644.14

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 05/19/2026, that is intended to comply with Rule 10b5-1(c).
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Richard Gelfond
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)